SEARCH
Current Location:
>
> This Story


Log in or Register to rate this News Story
Forward Printable StoryPrint Comment

Never Miss a Story

Sign Up For Weekly Top Stories

 

More Industry Headlines

Focused ultrasound treatment helps coma patient get back in action Portable device might be developed in future

Mylan CEO comments on ‘broken health care system’ amid EpiPen controversy Offers coupons up to $300

Researchers use zinc to identify prostate cancer under MR Diminished zinc levels may warn of cancer pervasiveness

HTMs are evolving into hospital leadership role: CEAI They are being heard and doing more — but it's still not enough

Who will step up after Mary Logan steps down? Big leadership shoes to fill for the AAMI

A call for vigilance against device-related accidents at CEAI Understanding where human and technical factors combine for disaster

Mallinckrodt sells nuclear imaging business to IBA Molecular for $690 million Company puts more focus on specialty pharmaceutical business

Study shows MR-guided focused ultrasound decreases essential tremors by almost half Research conducted with InSightec's ExAblate Neuro

Researchers devise edible batteries that could power ingestible medical devices Made of melanin and dissolvable materials

Medical device companies will pony up $1 billion under new FDA user fee agreement Funds will go toward improving device review program

Aurora and Sumec reps signing the deal. (Credit: Sumec)

Aurora inks breast MRI distribution deal in China

by Brendon Nafziger , DOTmed News Associate Editor
Aurora Imaging Technology Inc. said Monday it inked an exclusive deal with Sumec Group Corp. to distribute its breast MRI machines in China. Terms of the deal were not disclosed.

Sumec, a shipbuilding and engineering company, is a member of the state-owned China National Machinery Industry Corp., or Sinomach, conglomerate.

Story Continues Below Advertisement

PowerLook Advanced Mammography Platform

One Platform - Multiple Solutions. Superior algorithms support rapid & accurate detection. iReveal standardizes breast density assessment. Tomosynthesis CAD optimizes reading workflow. Learn more>



The American Cancer Society recommends women at high risk for breast cancer, such as those with the BRCA1 and BRCA2 mutations, receive a breast MRI scan every year, in addition to screening mammography.

Breast MRIs are more sensitive than X-rays at detecting cancers, especially for women with mammographically dense breasts. In fact, the two companies said the technology could be especially useful in China as breast density is greater, on average, in Asian women. A 2007 American Journal of Roentgenology study, for instance, found Asian women had denser breasts even after controlling for age and body-mass index.

The first iteration of Aurora's (now) 1.5-Tesla Dedicated Breast MRI System was cleared by the Food and Drug Administration in 1996. Privately held Aurora is based in North Andover, Mass.

Related:


Interested in Medical Industry News? Subscribe to DOTmed's weekly news email and always be informed. Click here, it takes just 30 seconds.

You Must Be Logged In To Post A Comment

Advertise
Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Directory
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Requests
Gold Service Dealer Program
Receive RFP/PS
Requests
Healthcare Providers
See all
HCP Tools
Jobs/Training
Find/Fill
A Job
Parts Hunter +EasyPay
Get Parts
Quotes
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Quotes
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2016 DOTmed.com, Inc.
ALL RIGHTS RESERVED